|Articles|September 22, 2004
- Pharmaceutical Executive-09-01-2004
September Table of Contents
TOC
Advertisement
Articles in this issue
over 21 years ago
(Huge) Untapped Opportunityover 21 years ago
Information Into Actionover 21 years ago
Halting the Hypeover 21 years ago
Spend Trends: A $20 Billion Bill and Plenty of Changeover 21 years ago
September Table of Contentsover 21 years ago
From the Mouths of Babesover 21 years ago
Safe and Secureover 21 years ago
Synta's Surpriseover 21 years ago
The New Building Blocks for Blockbustersover 21 years ago
Specialty Therapies Lose Special StatusNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
3
FDA Announces New Domestic-Manufacturing-Focused Pilot Program
4
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
5